Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786993 · ClinicalTrials.gov registry record · Phase 3
MultiPoint Pacing IDE Study
A Phase 3 study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- Phase 3
- Development phase
- 506
- Enrollment target
NCT01786993 is a Phase 3 study that has completed, run by Abbott Medical Devices. The registered enrollment target is 506 participants.
The verdict
NCT01786993, a Phase 3 study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 506 participants
- Enrollment target
Study Summary
This IDE study is a prospective, randomized, double-blind, multi-center clinical study to evaluate the safety and efficacy of patient treatment with MPP compared to patient treatment with standard BiV pacing at 9 months. The study will be conducted at a maximum of 50 investigational centers located in the United States. A maximum of 506 subjects implanted with the Quadripolar cardiac resynchronization therapy device (CRT-D) system will be enrolled in the study.
Interventions
- DEVICE MultiPoint Pacing
- DEVICE Traditional Biventricular Pacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 506 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01786993
The ClinicalTrials.gov registry entry for NCT01786993 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 506 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MultiPoint Pacing is the first listed.
NCT01786993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01786993 about?
NCT01786993 is a clinical study titled "MultiPoint Pacing IDE Study". This IDE study is a prospective, randomized, double-blind, multi-center clinical study to evaluate the safety and efficacy of patient treatment with MPP compared to patient treatment with standard BiV pacing at 9 months. The study will be conducted at a maximum of 50 investigational centers located...
What is the current status of trial NCT01786993?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 506 participants. The study started on 2013-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01786993?
The interventions under investigation include: MultiPoint Pacing (DEVICE), Traditional Biventricular Pacing (DEVICE).
Who is sponsoring clinical trial NCT01786993?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.